tiprankstipranks
Anebulo Pharmaceuticals (ANEB)
OTHER OTC:ANEB
US Market
ANEB
Anebulo Pharmaceuticals
RESEARCH TOOLSreports
Want to see ANEB full AI Analyst Report?

Anebulo Pharmaceuticals (ANEB) Income Statement

36 Followers

Anebulo Pharmaceuticals Income Statement

Last quarter (Q2 2026), Anebulo Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Anebulo Pharmaceuticals's net income was $-2.00M. See Anebulo Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.22M$ 8.31M$ 11.78M$ 6.83M$ 3.61M
Depreciation and Amortization
$ 0.00$ 258.28K$ 0.00$ 0.00$ 0.00
EBITDA
$ -8.10M$ -7.79M$ -11.73M$ -6.83M$ -30.24M
Operating Income
$ -9.22M$ -8.31M$ -11.78M$ -6.83M$ -3.61M
Other Income/Expenses
$ 738.72K$ 107.05K$ 51.26K$ 5.55K$ -26.64M
Pretax Income
$ -8.48M$ -8.20M$ -11.73M$ -6.83M$ -30.25M
Net Income
$ -8.48M$ -8.20M$ -11.73M$ -6.83M$ -30.25M
Per Share Metrics
Basic EPS
$ -0.25$ -0.32$ -0.47$ -0.29$ -1.30
Diluted EPS
$ -0.25$ -0.32$ -0.47$ -0.29$ -1.30
Weighted Average Shares Outstanding
 33.82M 25.82M 25.07M 23.34M 23.34M
Weighted Average Shares Outstanding (Diluted)
 33.82M 25.82M 25.07M 23.34M 23.34M
Currency in USD

Anebulo Pharmaceuticals Earnings and Revenue History